Furthermore, other activating receptors such as NKG2D, NKp30, NKp46, and DNAX accessory molecule-1 (DNAM-1) were reduced in the peripheral blood of patients with CRC (140–142). This evidence concerns the gene KLRK1 and colorectal carcinoma.